121 related articles for article (PubMed ID: 24084449)
1. Development of solid dispersions of artemisinin for transdermal delivery.
Shahzad Y; Sohail S; Arshad MS; Hussain T; Shah SN
Int J Pharm; 2013 Nov; 457(1):197-205. PubMed ID: 24084449
[TBL] [Abstract][Full Text] [Related]
2. Dissolution of artemisinin/polymer composite nanoparticles fabricated by evaporative precipitation of nanosuspension.
Kakran M; Sahoo NG; Li L; Judeh Z
J Pharm Pharmacol; 2010 Apr; 62(4):413-21. PubMed ID: 20604829
[TBL] [Abstract][Full Text] [Related]
3. Improved physicochemical characteristics of artemisinin-nicotinamide solid dispersions by solvent evaporation and freeze dried methods.
Ansari MT; Pervez H; Shehzad MT; Mahmood Z; Razi MT; Ranjha NM; Khanum N
Pak J Pharm Sci; 2012 Apr; 25(2):447-56. PubMed ID: 22459476
[TBL] [Abstract][Full Text] [Related]
4. Application of hot melt extrusion for improving bioavailability of artemisinin a thermolabile drug.
Kulkarni C; Kelly AL; Gough T; Jadhav V; Singh KK; Paradkar A
Drug Dev Ind Pharm; 2018 Feb; 44(2):206-214. PubMed ID: 29145748
[TBL] [Abstract][Full Text] [Related]
5. Application of Solid Dispersion Technique to Improve Solubility and Sustain Release of Emamectin Benzoate.
Huang BB; Liu DX; Liu K; Wu G
Molecules; 2019 Nov; 24(23):. PubMed ID: 31779169
[TBL] [Abstract][Full Text] [Related]
6. Development of solid dispersion systems of dapivirine to enhance its solubility.
Gorajana A; Ying CC; Shuang Y; Fong P; Tan Z; Gupta J; Talekar M; Sharma M; Garg S
Curr Drug Deliv; 2013 Jun; 10(3):309-16. PubMed ID: 23360246
[TBL] [Abstract][Full Text] [Related]
7. Improved physicochemical characteristics of artemisinin using succinic acid.
Ansari MT; Pervez H; Shehzad MT; Saeed-ul-Hassan S; Mehmood Z; Shah SN; Razi MT; Murtaza G
Acta Pol Pharm; 2014; 71(3):451-62. PubMed ID: 25265825
[TBL] [Abstract][Full Text] [Related]
8. Physicochemical characterization of artemether solid dispersions with hydrophilic carriers by freeze dried and melt methods.
Ansari MT; Karim S; Ranjha NM; Shah NH; Muhammad S
Arch Pharm Res; 2010 Jun; 33(6):901-10. PubMed ID: 20607495
[TBL] [Abstract][Full Text] [Related]
9. Physicochemical characterization and dissolution study of solid dispersions of Lovastatin with polyethylene glycol 4000 and polyvinylpyrrolidone K30.
Patel RP; Patel MM
Pharm Dev Technol; 2007; 12(1):21-33. PubMed ID: 17484141
[TBL] [Abstract][Full Text] [Related]
10. Hot melt extrusion based solid solution approach: Exploring polymer comparison, physicochemical characterization and in-vivo evaluation.
Fule R; Paithankar V; Amin P
Int J Pharm; 2016 Feb; 499(1-2):280-294. PubMed ID: 26746801
[TBL] [Abstract][Full Text] [Related]
11. Electrospinning of artemisinin-loaded core-shell fibers for inhibiting drug re-crystallization.
Shi Y; Zhang J; Xu S; Dong A
J Biomater Sci Polym Ed; 2013; 24(5):551-64. PubMed ID: 23565867
[TBL] [Abstract][Full Text] [Related]
12. Solvent-shift strategy to identify suitable polymers to inhibit humidity-induced solid-state crystallization of lacidipine amorphous solid dispersions.
Sun M; Wu C; Fu Q; Di D; Kuang X; Wang C; He Z; Wang J; Sun J
Int J Pharm; 2016 Apr; 503(1-2):238-46. PubMed ID: 26869398
[TBL] [Abstract][Full Text] [Related]
13. Drug-polymer miscibility, interactions, and precipitation inhibition studies for the development of amorphous solid dispersions for the poorly soluble anticancer drug flutamide.
Trivino A; Gumireddy A; Meng F; Prasad D; Chauhan H
Drug Dev Ind Pharm; 2019 Aug; 45(8):1277-1291. PubMed ID: 31111732
[TBL] [Abstract][Full Text] [Related]
14. Improvement of the dissolution rate of artemisinin by means of supercritical fluid technology and solid dispersions.
Van Nijlen T; Brennan K; Van den Mooter G; Blaton N; Kinget R; Augustijns P
Int J Pharm; 2003 Mar; 254(2):173-81. PubMed ID: 12623193
[TBL] [Abstract][Full Text] [Related]
15. Molecular interaction between glimepiride and Soluplus®-PEG 4000 hybrid based solid dispersions: Characterisation and anti-diabetic studies.
Reginald-Opara JN; Attama A; Ofokansi K; Umeyor C; Kenechukwu F
Int J Pharm; 2015 Dec; 496(2):741-50. PubMed ID: 26581773
[TBL] [Abstract][Full Text] [Related]
16. Characterization and solubility study of norfloxacin-polyethylene glycol, polyvinylpyrrolidone and carbopol 974p solid dispersions.
Gorajana A; Kit WW; Dua K
Recent Pat Drug Deliv Formul; 2015; 9(2):167-82. PubMed ID: 25714525
[TBL] [Abstract][Full Text] [Related]
17. Stability-enhanced hot-melt extruded amorphous solid dispersions via combinations of Soluplus® and HPMCAS-HF.
Alshahrani SM; Lu W; Park JB; Morott JT; Alsulays BB; Majumdar S; Langley N; Kolter K; Gryczke A; Repka MA
AAPS PharmSciTech; 2015 Aug; 16(4):824-34. PubMed ID: 25567525
[TBL] [Abstract][Full Text] [Related]
18. Thermodynamic phase behavior of API/polymer solid dispersions.
Prudic A; Ji Y; Sadowski G
Mol Pharm; 2014 Jul; 11(7):2294-304. PubMed ID: 24870944
[TBL] [Abstract][Full Text] [Related]
19. Improving the solubility and bioavailability of dihydroartemisinin by solid dispersions and inclusion complexes.
Ansari MT; Batty KT; Iqbal I; Sunderland VB
Arch Pharm Res; 2011 May; 34(5):757-65. PubMed ID: 21656361
[TBL] [Abstract][Full Text] [Related]
20. Solid dispersions of dihydroartemisinin in polyvinylpyrrolidone.
Ansari MT; Sunderland VB
Arch Pharm Res; 2008 Mar; 31(3):390-8. PubMed ID: 18409055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
